The sustainable loan market: A snapshot of recent developments
Since the publication of the Sustainability-Linked Loan Principles in 2019, global sustainability-linked loan volumes have shot past green loan levels. Sustainability-linked loans provide a good complement to green loans for companies pushing a broader sustainability strategy and are a relevant alternative for entities within sectors that are not green by nature.
Industry 4.0 is a business model revolution, not a technological revolution
Sandik's Hugo Nordell, Vice President of Strategy & Business Development, and Ulf Hermansson, Director of Strategic Execution share their view on level of digitalisation within Sandvik and what AMT actually does.
Investments that reduce food loss and waste can deliver two big wins: improving food security and reducing greenhouse gas emissions, according to the World Bank, which recently issued two bonds to raise awareness of the issue.
New equity capital was a matter of ‘safety first’
What do you do when a global pandemic breaks out while you are right in the midst of a major working capital reduction programme to bring down leverage? Stein Eriksen, CFO of XXL, highlights their rights issue, accelerated customer migration from stores to online shopping, and stronger preferences for staycation.
Lessons from the infant sustainability-linked bond market
In September 2020, the first bonds aligned to the Sustainability-Linked Bond Principles (SLBPs) were issued. Even though the fledgling market provides endless opportunities for structuring sustainability-linked bonds (SLBs), a comparison of the current issuers and their bonds reveals unexpected similarities.
Nordea launches its own ESG ratings for Nordic companies
The ratings system caters to a variety of investment strategies, allowing investors to tailor the output for their specific preferences. Marco Kisic, Nordea’s Head of ESG Research, explains the ins and outs.
Coronavirus: Plan B – Hope for the best, prepare for the worst
Covid-19 has given an unprecedented shock to the world economy, as lockdowns caused sudden and sharp declines in demand, and we cannot safely assume that development of a vaccine or other therapy will make it go away entirely.